finanzen.pr-Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule
08.08.2008 01:00:08
Abbott Laboratories: Mexico City (ots/PRNewswire) - - Pivotal Study of Norvir Tablet Bioavailability Will Form the Basis of Request for Priority Regulatory Review Abbott (NYSE: ABT) presented pivotal data at the XVII International AIDS Conference ...
Lesen Sie hier weiter... |
Drucken |
PDF
Ähnliche Artikel
- Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines
- Klöckner& Co: Second Annual General Meeting since IPO
- Wissenschaftler von Abbott stellen neuen Ansatz zur Behandlung der Aufmerksamkeitsdefizit-Hyperaktivitätsstörung vor
- Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
- Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
- Earnings in First Quarter 2008 at record levels: 26.5% pre-tax sales yield and 36.1% rate of growth
- Internationales Institut für vergleichende Studien politischen Kulturen hält seine erste Konferenz in Frankreich ab
- centrotherm photovoltaics concludes current share repurchase program
- Rating agency D&B confirms highest credit rating for AvW Group
- Stabilus erwirbt von Suspa den Geschäftsbereich Stuhlgasfedern